Anti-Racism Statement Anti-Racism Statement Osteoporosis Canada is committed to the removal of anti-Black systemic barriers negatively affecting the lives of Black Canadians. Osteoporosis Canada is committed to anti-racism and anti-oppression, […]

Bisphosphonate therapy – long term use Recently a study published by Drieling et al in JAGS 2017 described the results of a cohort study of 5120 older women with an […]

MEET THE CMC FACULTY Dr. Cathy Craven University of Toronto  Toronto, ON Cathy Craven is the Toronto Rehabilitation Institute/ University of Toronto Chair in Spinal Cord Injury (SCI) Rehabilitation, Professor […]

SIGNS AND SYMPTOMS A disease that develops without any symptoms. The First Warning Sign of Osteoporosis is Frequently A Fracture Osteoporosis is a disease that takes years to develop without […]

Last week, Osteoporosis Canada heard a news story that suggested that there is an increased risk of developing osteonecrosis of bone if you are taking a bisphosphonate medication for osteoporosis. […]

ABOUT THE DISEASE What is Osteoporosis? Osteoporosis is a disease that slowly, quietly weakens bones, often going undiagnosed – even when it breaks them. Osteoporosis is caused by low bone […]

As we work to adjust to our new normal during COVID-19, now more than ever, staying fracture-free is critical for anyone with osteoporosis. Healthcare systems are over-stretched, with general recommendations […]

Romosozumab EVENITY™ (romosozumab injection) Romosozumab, a sclerostin inhibitor, is the first new approach to the treatment of osteoporosis and fracture risk in almost a decade.Romosozumab (EVENITY™) significantly and rapidly (over […]

Take action to make sure you are staying fracture-free and are taking care of your bone health. This pandemic has put enormous pressure on our healthcare systems stretching our resources […]